Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3297631
Title:
ANTAGONISTE DES RECEPTEURS NK-1/NK-3 DESTINE AU TRAITEMENT DES BOUFFEES DE CHALEUR
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
167231075
WO application number:
EP2016060945
Type:
European patent granted for BE
Status:
Open
Publication number:
3297631
WO publication number:
WO2016184829
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
16/05/2016
Grant date:
04/09/2019
EP publication date:
28/03/2018
WO publication date:
24/11/2016
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
04/09/2019
EP B1 publication date:
04/09/2019
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
16/05/2036
Applicant
1
Name:
KANDY THERAPEUTICS LIMITED
Legal Form:
From:
05/02/2021
Address:
400 South Oak Way, Reading, Berkshire RG2 6AD, United Kingdom (GB)
To:
2
Name:
NeRRe Therapeutics Limited
Legal Form:
From:
04/09/2019
Address:
Stevenage Bioscience Catalyst
Office F25 Incubator Building
Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, United Kingdom (GB)
To:
05/02/2021
Agent
Name:
MURGITROYD & COMPANY
Legal Form:
From:
05/09/2019
Address:
Scotland House Scotland Str 165 169, G5 8PL, GLASGOW, United Kingdom (GB)
To:
01/01/2021
Inventor
Name:
TROWER, Mike
Legal Form:
Address:
Stevenage
Hertfordshire SG1 2FX, United Kingdom (GB)